Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

@article{Stein2004EfficacyOL,
  title={Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial},
  author={M. Stein and M. Pollack and A. Bystritsky and J. Kelsey and R. Mangano},
  journal={Psychopharmacology},
  year={2004},
  volume={177},
  pages={280-288}
}
  • M. Stein, M. Pollack, +2 authors R. Mangano
  • Published 2004
  • Medicine
  • Psychopharmacology
  • RationaleThere is a need for new pharmacological treatments for generalized social anxiety disorder (GSAD), which is a common, often disabling condition.ObjectiveTo compare the efficacy and safety over 6 months duration of two dose ranges of venlafaxine extended-release (ER) with placebo in patients with GSAD.MethodTwenty-eight-week, double-blind, multi-center study in 386 adult outpatients with DSM-IV GSAD. Patients were randomized to placebo, venlafaxine ER fixed low dose (75 mg/day), or… CONTINUE READING
    94 Citations

    Figures, Tables, and Topics from this paper

    A Randomized Controlled Trial of Atomoxetine in Generalized Social Anxiety Disorder
    • 25
    Treatment of anxiety disorders with venlafaxine XR
    • M. Thase
    • Medicine
    • Expert review of neurotherapeutics
    • 2006
    • 30
    Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials
    • 20
    • Highly Influenced
    The evidence-based pharmacotherapy of social anxiety disorder.
    • 63
    • PDF

    References

    SHOWING 1-10 OF 50 REFERENCES
    Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
    • 96
    • Highly Influential
    Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
    • 200
    Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder
    • 161
    • PDF
    Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.
    • 79
    Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    • 200
    A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    • 116
    Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
    • 190
    • Highly Influential
    Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.
    • 72
    Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    • 77